But whether that's good or bad isn't yet clear
by jca1008 on Tue Nov 04, 2008 12:00 AM
Thank you for posting about the places which are workign on treatments. Does anyone know how far these treatments are to becoming something mainstream and able to be obtained at the OB's office ?
by herenow on Sun Nov 09, 2008 12:00 AM
Roche has TG-4001, which is targeting HPV-16. Unless something has changed from what I previously read, Roche would like to release it in 2010 or 2011.
Nventa also has an even more promising therapeutic medication proving successful in clinical trial. It is HspE7. When I read information on HspE7, before it was combined with Poly-ICLC, other strains were impacted by it, which showed the genetic crossover. I think Nventa's work is the most exciting, although I'm happy by all the studies on medication.
There is also MVA E2, by Centre National de la Recherche Scientifique (CNRS), which is also proving successful at clearing up HPV-caused abnormalities.
I was shocked people weren't aware of it, before. I certainly wasn't aware there were any studies being done. When I asked doctors about therapeutic medication being developed, they all said there wasn't any. They said the current treatment is good enough, which is completely bogus! When I told them I had discovered there was therapeutic medication in the works and that I had been in contact, they all looked uncomfortable. Small wonder, right? Medication is going to change the face of gynecology.
I don't know which country you are in, but if you are in America, let me give you the links to contact your representatives in order to push the funding and legislature necessary to make this available. If you are in a different country, I'm sure you'll know how to notify your reps there to push for this and to inform other women.
The House of Representatives.
If you find out other information about therapeutic medication, please let us all know!
by jcr65566 on Sun Nov 09, 2008 12:00 AM
On 11/4/2008 jca1008 wrote:Thank you for posting about the places which are workign on treatments. Does anyone know how far these treatments are to becoming something mainstream and able to be obtained at the OB's office ?TY,Julie
Hi Jule The antigens, stimulating a cellular immune response to eradicate HPV16-induced cancers and pre-cancerous lesions. The problem is there is so many of variance of the HPV16 it can’t treat them all so untill they get it working better I think you can get a better effect just by using the old pre world war two remedy of colloidal silver witch was fazed out when we started using the antibiotics penicillin what do you think cheers Ray
As an aside, in speaking to one of the directors, it hasn't been easy getting funding to further test, research, and test the medication being developed because those who support surgery are putting up resistence. Surgery is a quick fix, but it won't protect a woman's life for the future. No matter what surgical procedure is developed, the success rate is still the same and the recurrence rate is still the same. I respect what the companies I mentioned are donig because they see the need to heal less invasively and protect the future health of women (and men) who have HPV-caused abnormalities and those who will have HPV-caused abnormalities. Exciting things are happening, and we can help bring this about!
There are definitely clinical trials taking place. The link is easy to follow. I'll give the link, but I feel compelled to give my thoughts on this before posting the link. Bear in mind, I respect a woman's right to make her own decision, but I still want to give my own words of caution.
1. There are always risks involved during clinical trials. It is critical to weigh them carefully before agreeing to be part of any study.
2. There is always a list of qualifications a candidate must meet before qualifying. Not only does this remove unnecessary variables that could make the results less accurate, but it protects the patient's life from unnecessary risks. Therefore, it is critical to be honest when answering the questions and to be especially forthcoming about any health issues when being screened. I can't emphasize this one enough.
3. The clinic where the studies are being conducted will monitor the candidate closely during the trial. But as an extra precaution, a patient should stay in close contact with her doctor. It is also wise to set up Plan B as backup, as a safeguard.
If anyone is looking into this, again, I respect a woman's choice to make the decision she believes is best for her body, but all I ask is that caution is exercised.
Here is the link.
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
We care about your feedback. Let us know how we can improve your CancerCompass experience.